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Abstract: Condensation products of 5-substituted phenyl-2-furoyl hydrazide with different 
monosaccharides  D-glucose,  D-galactose,  D-mannose,  D-fucose  and  D-arabinose  were 
prepared. The anomerization and cyclic-acyclic isomers were investigated by 
1H NMR 
spectroscopy. The results showed that, except for the D-glucose derivatives, which were in 
the presence of β-anomeric forms, all derivatives were in an acyclic Schiff base form. Their 
antifungal and antitumor activities were studied. The bioassay results indicated that some 
title compounds showed superior effects over the commercial positive controls. 
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1. Introduction 
Carbohydrates  participate  in  various  vital  processes,  showing  important  physiological  and 
biological activities. In a recent review, Becker and coworkers [1] emphasized that the introduction of 
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pharmacophores into sugar templates that possess dense stereochemical information is an excellent 
strategy  for  the  development of bioactive compounds with rich structural diversity. Free reducing 
sugars  (hemiacetal),  which  are  often  available  from  natural  sources,  react  with  α-heteroatom 
nucleophile hydrazide to give cyclic pyranoside adducts in predominantly β-anomeric form or the open 
chain  hydrazone  tautomer  [2–5].  In  fact,  this  intrinsic  chemoselective  condensation  reactivity  of 
carbohydrates has been skillfully employed in numerous applications, including biotin labeling [6–8], 
formation of glycoarrays [9–11], glycan capture for structural and functional glycomics [12–14], and 
the generation of glycopeptide analogues [15,16]. 
Hydrazones containing an azometine (Schiff base) –NHN=CH– group possess various bioactivities 
such  as  antimicrobial,  anticonvulsant,  analgesic,  antiinflammatory,  antiplatelet,  antitubercular  and 
antitumoral activities [17]. A very famous example is the isonicotinic acid hydrazide (isoniazid) which 
showed very high inhibitory activity towards Mycobacterium tuberculosis H37Rv in vivo. Researchers 
synthesized isoniazid- hydrazones derivatives that were reported to have inhibitory activity in mice 
infected  with  various  strains  of  M.  tuberculosis  and  also showed  less  toxicity  in  these  mice  than 
isoniazid [18] because of the blockage of –NH2 group. These findings further support the growing 
importance of the synthesis of hydrazide-hydrazones compounds [19]. 
In our previous work, based on the hydrazide moiety, some diacylhydrazines (B, Scheme 1) [20–24], 
semicarbazides (C, Scheme 1) [25], and acylhydrazones (D, Scheme 1) [26,27] derivatives containing 
5-phenyl-2-furan were designed and synthesized. All the compounds showed diverse and significant 
bioactivities such as fungicidal, insecticidal, and antitumor activities. In continuation of our research 
on the synthesis of biological heterocyclic compounds, a series of novel glycosyl hydrazide derivatives 
containing 5-phenyl-2-furan moiety were designed and synthesized (Scheme 1). The ring-chain isomers 
were investigated by 
1H NMR spectroscopy. Their antifungal and antitumor activities were evaluated. 
Scheme 1. Designed strategy for title compounds. 
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A: General structure of 5-phenyl-2-furoyl hydrazide derivatives
C: X was modified with N-benzamide carbonyl group (8) D: X was modified with phenylmethylidene group (9)
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2. Results and Discussion 
2.1. Synthesis and Structure Elucidation 
Glycosylhydrazides  were  obtained by  condensation  of equimolar  amounts  of  the  corresponding  
5-substituted phenyl-2-furoyl hydrazide with the monosaccharides D-glucose, D-galactose, D-mannose, 
D-fucose, and D-arabinose in ethanol (Scheme 2). 
Scheme 2. Condensation reactivity and equilibrium between cyclic and acyclic forms of 
the monosaccharide. III-1: Glc, R = 4-Cl; III-2: Gal, R = 4-Cl; III-3: Man, R = 4-Cl;  
III-4: Fuc, R = 4-Cl; III-5: Ara, R = 4-Cl; III-6: Glc, R = 2,4-di-F; III-7: Glc, R = 4-F;  
III-8: Glc, R = 4-NO2; III-9: Glc, R = 2-NO2; III-10: Glc, R = 2-Cl; III-11: Glc, R = 4-Me; 
III-12: Glc, R = 3-F. 
 
The structures of all the compounds were characterized by 
1H Nuclear Magnetic Resonance (NMR), 
Infrared Spectroscopy (IR) and High Resolution Mass Spectrometer (HRMS). In the IR spectra, the 
compounds showed absorption bands around 3200 to 3400 cm
−1 originating from the O–H and N–H 
stretching  vibration.  The  strong  bands  around  1640  to  1680  cm
−1  were  carbonyl  vibration  of  the 
secondary  amide.  The  bands  between  1600  and  1620  cm
−1  could  be  assigned  to  the  C= N  stretching 
vibration. Absorption bands around 1610, 1550 and 1475 cm
−1 were attributed to the frame vibration of the 
phenyl and furan ring. Absorption bands around 1430, 1330 and 1260 cm
−1 were attributed to the 
coupled modes of C–C and C–O stretching vibrations of the sugar residues [28,29]. The absorption 
bands around the 1150 and 1085 cm
−1 region are characteristic for the pyranose form of hydrazines, 
and those around the 1075 cm
−1 region for the acyclic form of hydrazones [2]. 
In  the 
1H  NMR  spectra,  the  ring-chain  tautomers  of  the  monosaccharides  were  obviously 
determined  by  the  chemical  shift  of  the  proton  in  secondary  amide  CO–NH  and  the  proton  in  
imine N=CH in DMSO-d6 solution (Table 1). 
If the isomer was a cyclic form, the signal of the amide CO–NH was appeared around 10.20 ppm 
and  there  was  no  imine  N=CH  signal,  meanwhile  the  other  N –NH  signal  was  appeared  around  
5.87  ppm  (Figure  1c).  If  the  isomer  was  an  acyclic  form,  the  signal  of  the  amide  CO–NH  was  
down-fileded to 11.50 ppm and the imine N=CH signal was appeared around 7.75 ppm (Figure 1e). 
The result showed that except the D-Glc, other monosaccharides such as D-Gal, D-Man, D-Fuc and  
D-Ara hydrazide derivatives were mainly the acyclic tautomers (Figure 1). The chemical shift of the 
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anomeric H-1 in glucose 3.89 ppm and the coupling constant of 8.25 Hz indicated that the glucose was 
in the presence of β isomer. 
Figure 1. 500 MHz 
1H NMR spectra of condensation products of 5-(4'-chlorophenyl)-2-furoyl 
hydrazide  with  different  monosaccharides:  D-arabinose  (a);  D-fucose  (b);  D-glucose  (c);  
D-galctose (d); and D-mannose (e) in DMSO-d6 solution. 
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The ring-chain interconversion of sugar hydrazones in solution usually depended on factors such as 
the sugar conformation, most probably on the proportion of aldehyde form in solution, the basicity of 
the  hydrazine  groups,  and  the  solvent  effect  of  proton-acceptor  ability.  About  the  solvent  effect  on  
ring-chain interconversion, there were evidence that sugar hydrazones were favorable to be acyclic form in 
dimethyl  sulfoxide-d6 solution  than  others,  such  as  pyridine-d5,  methanol-d4 and  deuterium  oxide [2].  
High pH values also stimulated the ring to chain conversion. The cyclic to acyclic conversion caused 
by increase in the basicity of hydrazine and the proton-acceptor ability of solvent might be interpreted 
according to the electronic theory. The strongly basic nitrogen atom of hydrazine group was in high 
electron-density. The electron could move easily from nitrogen to anomeric carbon of the sugars to form  
a C=N bong with sp
2 hybridized orbital. The solvent with strong proton-acceptor ability could increase the 
basicity of the hydrazine group owing to the proton bonding with N–H group. In our study, the same 
solution and hydrazine were used (Figure 1), suggesting that the ring-chain tautomer was mainly caused 
due to the different monosaccharides. Some research [2] showed that glucose was prone to be cyclic form 
especially in dimethylsulfoxide (DMSO) solution. In this study, only glucose derivatives gave the cyclic 
form, which was consistent with the reported result [2]. Although the tautomerism was analyzed by 
1H 
NMR,  these  were  only  the  states  in  DMSO  solution  and  did not  reflect  in  any  other  solutions  or  in 
physiological  environment.  The  equilibrium  could  move  in  other  solutions,  especially  under  the 
physiological situation. 
Table 1. 
1H NMR spectra data of the condensation products of 5-(4'-chlorophenyl)-2-furoyl 
hydrazide with different monosaccharides. 
Compounds  Monosaccharide 
Chemical Shift (500 MHz, DMSO-d6) 
Tautomer 
H-1  NH-1  NH-2 
III-1  Glc  3.89 (t, 8.5 Hz)  5.87 (t, 4.0 Hz)  10.18 (s)  β-pyronose 
III-2  Gal  7.85 (d, 6.0 Hz)  –  11.52 (s)  acyclic 
III-3  Man  7.75 (d, 6.5 Hz)  –  11.54 (s)  acyclic 
III-4  Fuc  7.84 (d, 6.5 Hz)  –  11.52 (s)  acyclic 
III-5  Ara  7.83 (d, 6.0 Hz)  –  11.53 (s)  acyclic 
2.2. Bioassay 
2.2.1. Fungicidal Activity 
The  fungicidal  activity  and  fungicidal  spectra  were  evaluated  by  preliminary  bioassay  against  
19 kinds of fungi (Table 2). 
The result showed that the title compounds had broad fungicidal spectra, and most of them possessed 
good activity against the tested fungi at 50 μg·mL
−1. Compound III-5 (Arabinose derivative) showed good 
activity  against  Phytophthora  infestans  and  moderate  activity  against  Phomopsis  aspamgi  and 
Cladosporium fulvum. Compound III-4 (Fucose derivative) showed moderate activity against P. aspamgi. 
Compound III-3 (Mannose derivative) showed good activity against P. infestans and Alternaria alternata. 
All the compounds had no activity against the Sclerotinia sclerotiorum except compound III-2 (Galactose 
derivative), which also showed excellent activity against the P. infestans, and moderate activity against  
A. alternate and P. aspamgi. For the glucose derivatives, fluorinated compounds such as III-6 (2,4-di-F), Int. J. Mol. Sci. 2014, 15  6746 
 
 
III-7  (4-F),  and  III-12  (3-F)  showed  better  activity  than  the  others.  Among  them,  compound  III-6 
exhibited excellent activity against P. infestans and compound III-7 showed excellent activity against P. 
aspamgi.  Both  compounds III-6 and  III-12 showed a significant  inhibition effect  on  Valsa mali and  
C. fulvum. Compound III-12 also showed good activity against A. alternate and P. aspamgi. Compounds  
III-1  and  III-9  showed  considerable  activity  against  Phytophthora  melonis.  Compound  III-11  
showed  some  inhibitory  effect  on  the  P.  melonis.  All  the  compounds  showed  poor  activities  
against  Fusarium  graminearum,  Pyricularia  oryzae,  Monilinia  ariae,  Gloeosporium  musarum,  
Fusarium  oxysporum  f.  sp.  Niveum,  Botrytis  cinerea  Pers.,  Colletotrichum  orbiculare,  
Alternaria dauci and Colletotrichum phomoides. 
EC50 and EC80 values against some fungi were studied and showed in Table 3. The EC50 values of 
III-2, III-5, III-8 against P. infestans were 4.493, 5.476, and 5.695 μg·mL
−1, respectively, which were 
better than that of the positive control carbendazim (EC50 = 5.943 μg·mL
−1). Among them, especially 
the compound III-8, which EC80 value of 195.839 μg·mL
−1 was also better than that of the positive 
carbendazim (EC80 = 219.690 μg·mL
−1). The EC50 and EC80 values of III-11 against Alternaria tenuis 
Nees  were  6.181  and  431.342  μg·mL
−1,  respectively,  which  were  better  than  that  of  the  positive  
control  thiram  (EC50  =  8.831 μg·mL
−1  and  EC80  =  608.260  μg·mL
−1).  The  EC50  of  III-7  against 
Colletotrichum gloeosporioides was 4.962 μg·mL
−1, which was close to that of the positive control  
carbendazim (EC50 = 4.613 μg·mL
−1), while its EC80 value of 210.254 μg·mL
−1 was better than that of 
the positive control (EC80 = 352.820 μg·mL
−1). Also for this compound, its EC50 against P. aspamgi 
was 2.737 μg·mL
−1, which was better than that of hymexazol (EC50 = 3.656 μg·mL
−1), while their 
EC80 was the same with each other. The EC50 values of III-1 and III-9 against P. melonis were 5.179 
and 7.586 μg·mL
−1. The activity of compound III-1 was close to that of the positive control mancozeb 
(EC50 = 5.408 μg·mL
−1) and better than compound III-9. Although their EC80 values of 840.493 and 
500.113 μg·mL
−1 were far away from that of the positive control mancozeb (EC80 = 211.870 μg·mL
−1), 
meanwhile the EC80 value of compound III-9 was much better than compound III-1. 
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Table 2. The preliminary bioassay against 19 fungi at 50 μg·mL
−1. 
Fungi 
Inhibitory Rate (%) ± SEM 
III-1  III-2  III-3  III-4  III-5  III-6  III-7  III-8  III-10  III-11  III-12  III-13 
Fusarium graminearum  –  23.44 ± 4.24  –  –  –  –  43.75 ± 4.96  –  –  –  –  – 
Pyricularia oryzae  –  30.24 ± 4.59  –  –  –  –  26.39 ± 4.41  –  64.41 ± 4.79  35.82 ± 4.79  –  – 
Phytophthora infestans  –  90.16 ± 2.98  73.24 ± 4.43  26.48 ± 4.41  77.48 ± 4.18  87.80 ± 3.27  –  41.67 ± 4.93  –  63.90 ± 4.80  38.20 ± 4.86  – 
Alternaria alternata  54.24 ± 4.98  58.13 ± 4.93  65.40 ± 4.76  –  –  32.18 ± 4.67  –  41.52 ± 4.93  –  22.15 ± 4.15  –  58.13 ± 4.93 
Valsa mali  41.64 ± 4.93  45.82 ± 4.98  46.94 ± 4.99  –  46.20 ± 4.99  79.13 ± 4.06  –  40.86 ± 4.92  45.07 ± 4.98  –  36.08 ± 4.80  53.73 ± 4.99 
Colletotrichum 
gloeosporioides 
–  –  –  –  24.92 ± 4.33  34.45 ± 4.75  40.29 ± 4.90  –  32.12 ± 4.67  32.12 ± 4.67  –  36.73 ± 4.82 
Monilinia ariae  –  –  –  39.31 ± 4.88  33.75 ± 4.73  –  –  –  –  –  21.90 ± 4.14  35.63 ± 4.79 
Gloeosporium musarum  –  21.75 ± 4.13  –  20.84 ± 4.06  34.76 ± 4.76  21.75 ± 4.13  30.13 ± 4.59  –  –  –  –  30.56 ± 4.61 
Fusarium oxysporum f. 
sp. Niveum 
–  29.94 ± 4.58  36.60 ± 4.82  27.94 ± 4.49  31.35 ± 4.64  –  –  –  25.03 ± 4.33  –  28.80 ± 4.53  24.73 ± 4.31 
Botrytis cinerea Pers.  –  –  28.09 ± 4.49  –  –  –  –  –  –  –  –  21.15 ± 4.08 
Colletotrichum orbiculare  –  –  –  42.45 ± 4.94  25.68 ± 4.37  –  38.73 ± 4.87  55.25 ± 4.97  –  21.46 ± 4.11  –  – 
Phytophthora melonis  58.03 ± 4.94  –  –  –  32.12 ± 4.67  31.03 ± 4.63  29.27 ± 4.55  –  –  –  32.55 ± 4.69  – 
Sclerotinia sclerotiorum  –  70.84 ± 4.54  –  –  –  32.76 ± 4.69  –  –  –  –  –  – 
Phomopsis aspamgi  –  64.71 ± 4.78  25.44 ± 4.36  69.36 ± 4.61  55.39 ± 4.97  –  43.89 ± 4.96  91.07 ± 2.85  31.07 ± 4.63  47.16 ± 4.99  67.29 ± 4.69  68.95 ± 4.63 
Alternaria dauci  20.09 ± 4.01  28.01 ± 4.49  –  37.92 ± 4.85  28.01 ± 4.49  22.77 ± 4.19  –  22.77 ± 4.19  –  22.77 ± 4.19  –  – 
Fusarium graminearum  55.56 ± 4.97  –  24.54 ± 4.30  –  –  –  –  26.28 ± 4.40  –  –  –  – 
Cladosporium fulvum  –  47.24 ± 4.99  42.81 ± 4.95  35.84 ± 4.80  54.22 ± 4.98  70.05 ± 4.58  –  50.09 ± 5.00  45.78 ± 4.98  42.81 ± 4.95  –  66.69 ± 4.71 
Colletotrichum phomoides  26.53 ± 4.41  –  48.98 ± 5.00  48.98 ± 5.00  –  –  26.53 ± 4.41  38.27 ± 4.86  –  –  –  – 
Alternaria tenuis Nees  21.84 ± 4.13  –  31.76 ± 4.66  24.39 ± 4.29  43.21 ± 4.95  31.76 ± 4.66  24.39 ± 4.29  –  –  41.00 ± 4.92  –  – 
– means no activity. 
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Table 3. Fungicidal activity of title compounds. 
Fungi  Compounds  R  Regression Equation  EC50 (95% Confidence Interval)/μg·mL
−1  EC80 (95% Confidence Interval)/μg·mL
−1 
P. infestans 
III-2  0.987  y = 2.283x − 10.678  5.476 (4.857~6.132)  456.337 (405.314~511.740) 
III-5  0.988  y = 2.294x − 10.715  5.695 (5.107~6.335)  485.901 (435.433~540.053) 
III-6  0.999  y = 1.950x − 9.10  4.493 (4.426~4.507)  195.839 (193.750~197.278) 
mancozeb  0.969  y = 1.923x − 8.973  4.385 (3.329~5.776)  182.460 (138.293~239.924) 
A. tenuis Nees 
III-11  0.979  y = 2.191x − 10.165  6.181 (5.111~7.437)  431.342 (356.891~519.335) 
thiram  0.976  y = 2.183x − 9.969  8.831 (8.144~9.574)  608.260 (559.935~658.234) 
C. gloeosporioides 
III-7  0.991  y = 1.932x − 8.964  4.962 (4.580~5.384)  210.254 (193.593~227.579) 
carbendazm  0.993  y = 2.237x − 10.521  4.613 (4.331~4.912)  352.820 (330.646~375.017) 
P. aspamgi 
III-7  0.977  y = 1.732x − 8.222  2.737 (2.232~3.366)  78.767 (64.0567~96.5630) 
hymexazol  0.985  y = 2.018x − 9.527  3.656 (2.232~3.366)  78.770 (64.057~96.563) 
P. melonis 
III-1  0.985  y = 2.427x − 11.254  7.586 (6.647~8.696)  840.493 (733.256~959.342) 
III-9  0.996  y = 2.354x − 11.053  5.179 (5.027~5.403)  500.113 (481.424~517.398) 
mancozeb  0.991  y = 1.892x − 8.727  5.408 (4.987~5.863)  211.870 (195.086~229.334) Int. J. Mol. Sci. 2014, 15  6749 
 
2.2.2. Antitumor Activity 
Antitumor activity of title compounds was checked. The antitumor activity in Table 4 showed that 
some  title  compounds  had  great  activity  against human  promyelocytic  leukemic cells (HL-60).  In 
which, the activity of compounds III-3, III-4 and III-5 (IC50 = 6.9, 1.2, and 19.4 μM) was better than 
that of the positive control doxorubicin (IC50 = 28.4 μM). Some compounds exhibited good activity 
against human gastric carcinoma cells (BGC-823), such as III-4, III-5, and III-6 (IC50 = 6.9, 1.2, and 
19.4  μM),  but  which  were  lower  than  that  of  the  doxorubicin  (IC50  =  8.5  μM).  Against  human 
nasopharyngeal carcinoma cells (KB), only compound III-3 showed better activity (IC50 = 9.0 μM) 
than  the positive control doxorubicin  (IC50 = 28.4  μM). All  the  compounds  showed  poor activity 
against human hepatocellular carcinoma cells (Bel-7402). 
Table 4. Antitumor activity of the title compounds. 
Compounds 
IC50 (μM) 
HL-60  BGC-823  Bel-7402  KB 
III-1  267.9  184.6  2.6 × 10
5  586.2 
III-2  167.0  90.9  133.4  166.8 
III-3  6.8  151.9  144.5  9.0 
III-4  1.2  34.0  169.9  31.9 
III-5  19.4  47.2  106.8  118.9 
III-6  31.7  43.5  110.4  40.7 
III-7  78.9  193.3  356.7  489.2 
III-8  61.9  96.1  258.0  116.6 
III-9  38.7  550.2  178.3  337.8 
III-10  1523.4  92.8  174.8  1.2 × 10
5 
III-11  5797.3  119.3  2.5 × 10
4  100.7 
III-12  315.1  76.2  3.5 × 10
6  1588.0 
doxorubicin  28.4  8.5  6.7  11.9 
The  preliminary  structure-activity  relationship  analysis  indicated  that  compounds  containing  
Man (III-3), Fuc (III-4), and Ara (III-5) showed better activity against human promyelocytic leukemic 
cells (HL-60). Although the compounds containing glucose showed poorer activity against HL-60 than 
doxorubicin, some of them also possessed considerable activity, and the substituted group had obvious 
effects on the activity. The compounds with fluoride and nitro group on the ortho (III-6 and III-9) or 
para-position (III-7 and III-8) showed better activity than the others. It could be deduced that the 
skeleton of 5-phenyl-2-furoyl hydrazide (hydrazone) displayed important antitumor activity, which 
was in agreement with our former results [20–24,26,27]. 
3. Experimental Section  
3.1. General Information 
All  the  melting  points  were  determined  with  a  Cole-Parmer  melting  point  apparatus  while  the 
thermometer was uncorrected. IR spectra were recorded on a NEXUS-470 FTIR (Nicolet) spectrometer 
with KBr pellets. 
1H NMR spectra were recorded with Bruker DPX300 (Bruker, Billerica, MA, USA) and  Int. J. Mol. Sci. 2014, 15  6750 
 
 
JEOL  JNM-ECA500  instrument  (JEOL  Ltd., Tokyo,  Japan),  while  tetramethylsilane  was  used  as  the 
internal standards. HRMS was performed with Bruker APEX IV instrument (Bruker, Billerica, MA, USA). 
Analytical thin-layer chromatography (TLC) was carried out on precoated plates (silica gel 60 F254).  
The  developing  solvents  were  chloroform  and  methanol  (v/v:  6/1),  and  spots  were  visualized  with 
ultraviolet (UV) light. 
3.2. Synthetic Procedures 
3.2.1. General Synthetic Procedure for the Key Intermediates 
Intermediates II were synthesized from substituted aniline by Meerwein arylation reaction using the 
reported procedure [20–27]. 
3.2.2. General Synthetic Procedure for the Title Compounds III 
A mixture of monosaccaride I (0.05 mol) and 5-substituted phenyl-2-furoyl hydrazide II (0.05 mol) 
reacted in ethanol under reflux for 6–8 h. The reaction was catalyzed by drops of acetic acid. After 
cooling,  the  solvent  was  removed  under  reduced  pressure,  and  the  solid  was  recrystallized  from 
ethanol to obtain the target compounds III. 
All  the  synthesized  compounds  were  solid.  Their  structures  were  confirmed  by 
1H  NMR,  IR,  
and ESI-HRMS. 
N-(β-D-Glucopyranosyl)-N'-5-(4-chlorophenyl)-2-furoyl  hydrazine  (III-1).  Yield  86%,  
m.p. 174–175 °C. Rf = 0.22. IR (KBr) νmax: 3254.29 (hydrazine, N–H), 2874.93 (aromatic, C=C–H), 
1635.34 (hydrazide, C=O), 1475.28, 1364.39, 1321.00 (aromatic, C=C), 1278.57, 1221.68 (aromatic, 
C–C  and  C–O),  1195.65,  1164.79,  1090.55,  1028.84  cm
−1. 
1H  NMR  (500  MHz,  DMSO-d6)  
δ: 3.01 (t, 1H, J = 9.5 Hz, H-4), 3.05 (t, 1H, J = 8.5 Hz, H-2), 3.14–3.24 (m, 2H, H-3, H-5), 3.48 (dd, 
1H, J = 11.5, 5.5 Hz, H-6a), 3.72 (dd, 1H, J = 11.5, 2.5 Hz, H-6b), 3.89 (d, 1H, J = 8.5 Hz, H-1),  
7.17  (d,  1H, J = 3.5  Hz,  FuH), 7.28  (d,  1H, J = 3.5  Hz,  FuH),  7.54  (d,  1H, J = 9.0  Hz,  PhH),  
7.67  (d,  1H, J = 8.5  Hz,  PhH),  7.90  (d,  1H, J = 8.5  Hz,  PhH),  7.97 (d,  1H, J = 8.5  Hz,  PhH).  
ESI-HRMS calcd. for C17H19ClN2O7: [M + H]
+ 399.0959; Found: 399.0965. 
Aldehydo-D-Galactose-5-(4-chlorophenyl)-2-furoyl hydrazone (III-2). Yield 81%, m.p. 204–205 °C. 
Rf  =  0.23. IR  (KBr)  νmax:  3486.75,  3208.00  (hydrazone,  N–H),  2848.79  (aromatic,  C=C –H),  
1664.27 (hydrazide, C=O), 1625.15 (hydrazone, C=N), 1554.34, 1475.28 (aromatic, C=C), 1375.96, 
1302.68, 1222.65 (aromatic, C–C and C–O), 1182.15, 1083.80, 1053.91 cm
−1. 
1H NMR (500 MHz, 
DMSO-d6) δ : 3.35–3.40 (m, 2H, H-4, H-6b), 3.50–3.54 (m, 2H, H-3, H-6a), 3.70 (q, 1H, J = 6.5 Hz,  
H-5), 4.16 (d, 1H, J = 6.5 Hz, H-2), 7.16 (d, 1H, J = 3.5 Hz, FuH), 7.31 (d, 1H, J = 3.5 Hz, FuH), 7.52 
(d, 2H, J = 9.0 Hz, PhH), 7.65 (d, 1H, J = 8.5 Hz, PhH), 7.85 (d, 1H, J = 6.0 Hz, CH=N), 7.93 (d, 1H,  
J = 8.0 Hz, PhH). ESI-HRMS Calcd. for C17H19ClN2O7: [M + H]
+ 399.0959; Found: 399.0946. 
Aldehydo-D-Mannose-5-(4-chlorophenyl)-2-furoyl hydrazone (III-3). Yield 78%, m.p. 192–193 °C. 
Rf = 0.19. IR (KBr) νmax: 3268.75 (hydrazone, N–H), 2938.67 (aromatic, C=C–H), 1677.77 (hydrazide, 
C=O),  1619.47  (hydrazone,  C=N),  1551.45,  1473.35,  1409.71  (aromatic,  C=C),  1298.82,  1275.68, 
1222.65 (aromatic, C–C and C–O), 1173.47, 1075.12, 1028.84 cm
−1. 
1H NMR (500 MHz, DMSO-d6)  
δ: 3.36–3.40 (m, 1H, H-5), 3.43–3.48 (m, 1H, H-6a), 3.54 (t, 1H, J = 8.0 Hz, H-4), 3.59–3.62 (m, 1H, Int. J. Mol. Sci. 2014, 15  6751 
 
 
H-6b), 3.69 (t, 1H, J = 8.0 Hz, H-3), 4.05–4.09 (m, 1H, H-2), 7.17 (d, 1H, J = 3.5 Hz, FuH), 7.30 (d, 
1H, J = 3.5 Hz, FuH), 7.52 (d, 1H, J = 8.5 Hz, PhH), 7.66 (d, 1H, J = 8.5 Hz, PhH), 7.75 (d, 1H,  
J = 6.5 Hz, CH=N), 7.86 (d, 1H, J = 8.0 Hz, PhH), 7.93 (d, 1H, J = 8.0 Hz, PhH). ESI-HRMS Calcd. 
for C17H19ClN2O7: [M + H]
+ 399.0959; Found: 399.0968. 
Aldehydo-D-Fucose-5-(4-chlorophenyl)-2-furoyl hydrazone  (III-4). Yield 74%, m.p. 212–213 °C.  
Rf = 0.18. IR (KBr) νmax: 3485.69, 3225.36 (hydrazone, N–H), 2897.43 (aromatic, C=C–H), 1663.30 
(hydrazide, C=O), 1620.21 (hydrazone, C=N), 1552.42, 1475.28 (aromatic, C=C), 1376.93, 1300.75, 
1221.68  (aromatic,  C–C  and  C–O),  1180.22,  1025.94  cm
–1. 
1H  NMR  (500  MHz,  DMSO-d6)  
δ: 1.07 (d, 1H, J = 6.5 Hz, CH3), 3.26 (t, 1H, J = 8.0 Hz, H-4), 3.49 (t, 1H, J = 8.5 Hz, H-5), 3.86–3.89 
(m, 1H, H-3), 4.34–4.36 (m, 1H, H-2), 7.17 (d, 1H, J = 3.5 Hz, FuH), 7.31 (d, 1H, J = 3.5 Hz, FuH),  
7.52 (d, 2H, J = 8.5 Hz, PhH), 7.65 (d, 1H, J = 9.0 Hz, PhH), 7.84 (d, 1H, J = 6.5 Hz, CH=N), 7.93  
(d, 1H, J = 8.0 Hz, PhH). ESI-HRMS Calcd. for C17H19ClN2O6: [M + H]
+ 383.1010; Found: 383.1023. 
Aldehydo-D-Arabinose-5-(4-chlorophenyl)-2-furoyl  hydrazone  (III-5).  Yield  72%,  m.p.  
212–213  °C.  Rf  =  0.20. IR  (KBr)  νmax:  3442.31,  3076.18  (hydrazone,  N–H),  2845.34  (aromatic,  
C=C–H), 1666.47 (hydrazide, C=O), 1627.63 (hydrazone, C=N), 1546.63, 1473.35 (aromatic, C=C), 
1322.93, 1272.79 (aromatic, C–C and C–O), 1169.62, 1061.62, 1036.55 cm
–1. 
1H NMR (500 MHz, 
DMSO-d6)  δ:  3.36–3.43  (m,  2H,  H-3,  H-5a),  3.49–3.54  (m,  1H,  H-5b),  3.56–3.60  (m,  1H,  H-4),  
4.31–4.33 (m, 1H, H-2), 7.16 (d, 1H, J = 3.5 Hz, FuH), 7.30 (d, 1H, J = 3.5 Hz, FuH), 7.52 (d, 1H,  
J = 9.0 Hz, PhH), 7.65 (d, 1H, J = 8.5 Hz, PhH), 7.83 (d, 1H, J = 6.0 Hz, CH=N), 7.86 (d, 1H,  
J = 8.5 Hz, PhH), 7.93 (d, 1H, J = 8.5 Hz, PhH). ESI-HRMS Calcd. for C16H17ClN2O6: [M + H]
+ 
369.0853; Found: 369.0842. 
N-(β-D-Glucopyranosyl)-N'-5-(2,4-difluorophenyl)-2-furoyl  hydrazine  (III-6).  Yield  75%,  
m.p.  184–185 °C.  Rf =  0.23 .  IR (KBr) νmax:  3284.18 (hydrazine,  N–H),  2931.26 (aromatic,  C=C –H), 
1655.59  (hydrazide,  C=O) ,  1578.45,  1483.96  (aromatic,  C=C),  1313.29,  1272.79  (aromatic,  C–C  and  
C–O), 1029.80 cm
–1. 
1H NMR (300 MHz, DMSO-d6) δ: 3.06–3.09 (m, 2H, H-2, H-4), 3.14–3.24 (m, 2H, 
H-3, H-5), 3.49 (dd, 1H, J = 11.7, 5.1 Hz, H-6a), 3.83 (dd, 1H, J = 12.0, 2.4 Hz, H-6b), 3.93 (d, 1H,  
J = 8.1 Hz, H-1), 6.96 (t, 1H, J = 3.6 Hz, FuH), 7.20–7.32 (m, 2H, FuH + PhH), 7.44–7.47 (m, 1H, PhH), 
8.18–8.21 (m, 1H, PhH). ESI-HRMS Calcd. for C17H18F2N2O7: [M + H]
+ 401.1160; Found: 401.1176. 
N-(β-D-Glucopyranosyl)-N'-5-(4-fluorophenyl)-2-furoyl  hydrazine  (III-7).  Yield  84%,  
m.p.  200–201 °C.  Rf =  0.22. IR (KBr) νmax:  3447.13 (hydrazine,  N–H),  2933.20 (aromatic,  C=C –H), 
1635.34  (hydrazide,  C=O) ,  1560.13,  1489.74  (aromatic,  C=C),  1314.25,  1224.58  (aromatic,  C–C  and  
C–O), 1158.04, 1025.94 cm
–1. 
1H NMR (300 MHz, DMSO-d6) δ: 3.06–3.10 (m, 2H, H-2, H-4), 3.14–3.24 
(m, 2H, H-3, H-5), 3.48 (dd, 1H, J = 12.3, 5.6 Hz, H-6a), 3.81 (dd, 1H, J = 12.2, 2.7 Hz, H-6b), 3.92 (d, 1H,  
J = 8.7 Hz, H-1), 7.14 (d, J = 3.6 Hz, 1H, FuH), 7.33 (d, J = 3.6 Hz, 1H, FuH), 7.37 (d, J = 9.0 Hz, 2H, 
PhH), 7.99–8.02 (m, 2H, PhH). ESI-HRMS Calcd. for C17H19FN2O7: [M + H]
+ 383.1255; Found: 383.1267. 
N-(β-D-Glucopyranosyl)-N'-5-(4-nitrophenyl)-2-furoyl  hydrazine  (III-8).  Yield  72%,  
m.p. 124–125 °C. Rf = 0.21. IR (KBr) νmax: 3344.93 (hydrazine, N–H), 2968.74 (aromatic, C=C–H), 
1614.13 (hydrazide, C=O), 1486.85 (aromatic, C=C), 1332.57 (aromatic, C–C and C–O), 1078.01, 
1021.12 cm
−1. 
1H NMR (300 MHz, DMSO-d6) δ: 3.06 (t, 1H, J = 9.6 Hz, H-4), 3.08 (t, 1H, J = 8.1 Hz, 
H-2), 3.18−3.24 (m, 2H, H-3, H-5), 3.49 (m, 1H, H-6a), 3.74 (m, 1H, H-6b), 3.91 (d, 1H, J = 8.5 Hz,  
H-1), 7.36 (d, 1H, J = 3.6 Hz, FuH), 7.58−7.63 (m, 3H, FuH + 2PhH), 8.30 (d, 2H, J = 9.0 Hz, PhH). 
ESI-HRMS Calcd. for C17H19N3O9: [M + H]
+ 410.1200; Found: 410.1189. Int. J. Mol. Sci. 2014, 15  6752 
 
 
N-(β-D-Glucopyranosyl)-N'-5-(2-nitrophenyl)-2-furoyl  hydrazine  (III-9).  Yield  69%,  
m.p. 133–134 °C. Rf = 0.23. IR (KBr) νmax: 3290.93 (hydrazine, N–H), 2897.86 (aromatic, C=C–H), 
1646.91 (hydrazide, C=O), 1586.77, 1519.63, 1472.38 (aromatic, C=C), 1356.68, 1316.18, 1251.57 
(aromatic, C–C and C–O), 1077.05 cm
−1. 
1H NMR (300 MHz, DMSO-d6) δ: 3.04–3.10 (m, 2H, H-2, H-4), 
3.12–3.21 (m, 2H, H-3, H-5), 3.46 (m, 1H, H-6a), 3.80 (m, 1H, H-6b), 3.95 (d, 1H, J = 8.5 Hz, H-1), 
6.90 (d, J = 3.5 Hz,1H, FuH), 7.34 (d, J = 3.5 Hz, 1H, FuH), 7.65–7.69 (m, 2H, PhH), 7.78–7.82 (m, 1H, 
PhH), 7.97–8.01 (m, 1H, PhH). ESI-HRMS Calcd. for C17H19N3O9: [M + H]
+ 410.1200; Found: 410.1219. 
N-(β-D-Glucopyranosyl)-N'-5-(2-chlorophenyl)-2-furoyl  hydrazine  (III-10).  Yield  81%,  
m.p. 160–161 °C. Rf = 0.21. IR (KBr) νmax: 3320.82 (hydrazine, N–H), 2925.48 (aromatic, C=C–H), 
1654.62  (hydrazide,  C=O) ,  1560.13,  1472.38  (aromatic,  C=C),  1315.21(aromatic,  C–C  and  C–O), 
1073.19 cm
–1. 
1H NMR (300 MHz, DMSO-d6) δ: 3.01 (t, 1H, J = 9.6 Hz, H-4), 3.06 (t, 1H, J = 8.7 Hz, 
H-2), 3.12–3.24 (m, 2H, H-3, H-5), 3.46 (dd, 1H, J = 12.6, 5.1 Hz, H-6a), 3.82 (dd, 1H, J = 12.6,  
2.7 Hz, H-6b), 3.92 (d, 1H, J = 8.4 Hz, H-1), 7.31 (d, J = 3.6 Hz, 1H, FuH), 7.39 (d, J = 3.6 Hz, 1H, 
FuH), 7.43–7.54 (m, 2H, PhH), 7.60–7.63 (m, 1H, PhH), 8.18–8.22 (m, 1H, PhH). ESI-HRMS Calcd. 
for C17H19ClN2O7: [M + H]
+ 399.0959; Found: 399.0968. 
N-(β-D-Glucopyranosyl)-N'-5-(4-methylphenyl)-2-furoyl  hydrazine  (III-11).  Yield  79%,  
m.p. 180–181 °C. Rf = 0.23. IR (KBr) νmax: 3456.78 (hydrazine, N–H), 2906.20 (aromatic, C=C–H), 
1638.23 (hydrazide, C=O), 1577.49, 1491.67, 1454.06 (aromatic, C=C), 1313.29, 1271.82 (aromatic, 
C–C and C–O), 1078.01, 1018.23 cm
–1. 
1H NMR (300 MHz, DMSO-d6) δ: 2.34 (s,3H,CH3), 3.02  
(t, 1H, J = 9.6 Hz, H-4), 3.06 (t, 1H, J = 8.1 Hz, H-2), 3.16–3.23 (m, 2H, H-3, H-5), 3.49 (dd, 1H,  
J = 12.3, 5.1 Hz, H-6a), 3.69 (dd, 1H, J = 12.2, 2.7 Hz, H-6b), 3.95 (d, 1H, J = 8.8 Hz, H-1), 7.02  
(d, 1H, J = 3.6 Hz, FuH), 7.27–7.33 (m, 3H, FuH +2PhH), 7.78–7.83 (m, 2H, PhH). ESI-HRMS Calcd. 
for C18H22N2O7: [M + H]
+ 379.1505; Found: 379.1516. 
N-(β-D-Glucopyranosyl)-N'-5-(3-fluorophenyl)-2-furoyl  hydrazine  (III-12).  Yield  78%,  
m.p. 184–185 °C. Rf = 0.22. IR (KBr) νmax: 3380.60 (hydrazine, N–H), 2879.62 (aromatic, C=C–H), 
1660.41 (hydrazide, C=O), 1587.13, 1473.35, 1412.60 (aromatic, C=C), 1316.18 (aromatic, C–C and 
C–O), 1194.69, 1074.16, 1028.84 cm
−1. 
1H NMR (300 MHz, DMSO-d6) δ: 3.02–3.10 (m, 2H, H-2, H-4), 
3.12–3.21 (m, 2H, H-3, H-5), 3.43 (dd, 1H, J = 12.3, 5.1 Hz, H-6a), 3.76 (dd, 1H, J = 12.6, 2.7 Hz,  
H-6b), 3.92 (d, 1H, J = 8.4 Hz, H-1), 7.26–7.31 (m, 2H, FuH + PhH), 7.45 (d, J = 3.6 Hz, 1H, FuH), 
7.55–7.58 (m, 1H, PhH), 7.74–7.77 (m, 1H, PhH), 7.98–8.01 (m, 1H, PhH). ESI-HRMS Calcd. for 
C17H19FN2O7: [M + H]
+ 383.1255; Found: 383.1264. 
3.3. Bioassay 
3.3.1. Fungicidal Activity 
The  fungicidal  activity  and  antifungal  spectra  of  title  compounds  were  evaluated  using  the 
mycelium growth rate test at 50 μg·mL
−1. The fungi were provided and maintained by Department of 
Applied  Chemistry,  College  of  Science,  China  Agricultural  University,  Beijing,  China.  The 
commercial fungicides mancozeb, carbendazim, thiram, and hymexazol were used as positive controls. 
EXCEL2007 was applied to analyze bioassay data. Analysis of difference significance was performed 
using SPSS v.18.0 (SPSS Inc., Chicago, IL, USA). Int. J. Mol. Sci. 2014, 15  6753 
 
 
The fungicidal activity of title compounds was assessed using the radial growth test on potato 
dextrose agar (PDA). The compounds were dissolved in acetone and mixed with sterile molten PDA to 
obtain different concentrations of 50, 25, 12.5, 6.25, 3.13, 1.56 and 0.78 μg·mL
−1. Three replicates were 
used per treatment. After an incubation period of 96 h at 23 °C under a regular 12:12 h light:dark regimen, 
mycelial growth diameters were measured and the inhibition percentages relative to the control with 1% 
acetone were calculated. The inhibition rate was calculated according to the following formula: 
% 100 / ) ( 1 0 1 1 × − = D D D I   (1) 
where I1 is the inhibition rate,  1 D  is the average area of mycelia in the blank test, and  0 D  is the 
average area of mycelia in the presence of compounds. The EC50 and EC80 values were calculated 
using log-probit analysis, and the results were given in Table 1. 
3.3.2. Antitumor Activity 
All the title compounds were dissolved in DMSO and screened for preliminary anticancer activity 
against  four  different  cell  lines:  a  human  promyelocytic  leukemic  cell  line  (HL-60),  a  human 
hepatocellular carcinoma cell line (Bel-7402), a human gastric carcinoma cell line (BGC-823), and a 
human nasopharyngeal carcinoma cell line (KB) at concentration gradient of 0.1, 1.0, 10, 50 and 100 μM. 
The  commercial  drug  doxorubicin  was  used  as  positive  control  in  the  bioassay.  Three  replicates  
were performed. 
The four types of cell line were grown and maintained in RPMI-1640 medium supplemented with 
10% fetal bovine serum (FBS), penicillin (100 U·mL
−1), and streptomycin (100 μg·mL
−1) at 37 °C in 
humidified incubators in an atmosphere of 5% CO2. 
All the experiments were performed on exponentially growing cancer cells. Numbers of viable cancer 
cells were determined by MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazoliumbromide]) [30] and 
SRB (sulforhodamine B) [31] assays. The cancer cells (1 ~ 2.5 × 10
4 cells·mL
−1) were inoculated in  
96-well culture plates (180 μL/well). After 24 h, 20 μL of culture medium containing compounds of 
various  concentrations were added  to the  wells  and,  the  cells  were  incubated  for  48  h.  20  μL  of  
RPMI-1640  medium  was  added  to  the  control  cells.  HL-60  cells  were  assayed  by  MTT,  and  the  
Bel-7402, BGC-823 and KB cells were assayed by SRB. The absorbance of each well was measured 
using  a  microculture  plate  reader  at  570  nm  (MTT)  and  540  nm  (SRB).  The  inhibition  rate  was 
calculated according to the following formula: 
Inhibition rate = (ODcontrol − ODtreated)/ODcontrol × 100%  (2) 
4. Conclusions 
In summary, a novel series of N-glycosyl-N'-(5-substituted phenyl-2-furoyl) hydrazide derivatives were 
synthesized  in  good  yields.  The  anomerization  and  ring-chain  isomers  were  confirmed  by 
1H  NMR 
spectroscopy. Their antifungal and antitumor tests indicated that some title compounds showed superiority 
over the commercial positive controls during the present studies. Comparing title compounds III with lead 
compounds B (diacylhydrazides), C (semicarbazides), and D (acylhydrazones) (Scheme 1), it can be seen 
that the modification with sugars in hydrazide molecules is important for improving the antifungal and 
antitumor activity. These compounds could be lead compounds for further development. Int. J. Mol. Sci. 2014, 15  6754 
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